Brent Douty

1.2k total citations
14 papers, 607 citations indexed

About

Brent Douty is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Brent Douty has authored 14 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Brent Douty's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Chemical Synthesis and Analysis (4 papers) and Protein Tyrosine Phosphatases (4 papers). Brent Douty is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Chemical Synthesis and Analysis (4 papers) and Protein Tyrosine Phosphatases (4 papers). Brent Douty collaborates with scholars based in United States and Germany. Brent Douty's co-authors include Andrew P. Combs, Timothy C. Burn, Eddy W. Yue, Brian Wayland, Richard Wynn, Roland E. Dolle, Joseph M. Salvino, Min Wei, Michael J. Bower and David G. Sawutz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Brent Douty

14 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brent Douty United States	9	379	167	154	153	101	14	607
Brian Metcalf United States	10	221 0.6×	91 0.5×	53 0.3×	153 1.0×	84 0.8×	18	578
Nilla Avanzi Italy	15	459 1.2×	59 0.4×	19 0.1×	64 0.4×	263 2.6×	27	778
Puranik Purushottamachar United States	18	669 1.8×	44 0.3×	17 0.1×	46 0.3×	145 1.4×	45	1.0k
Jos de Man Netherlands	13	262 0.7×	46 0.3×	40 0.3×	53 0.3×	122 1.2×	22	497
Peter Lockey United Kingdom	18	385 1.0×	164 1.0×	6 0.0×	26 0.2×	135 1.3×	34	876
Ana Isabel Hernández Spain	18	492 1.3×	38 0.2×	72 0.5×	10 0.1×	96 1.0×	28	828
Anna A. Rybczynska Netherlands	12	402 1.1×	66 0.4×	12 0.1×	22 0.1×	93 0.9×	20	566
Mustapha Haddach United States	16	800 2.1×	36 0.2×	29 0.2×	34 0.2×	215 2.1×	26	1.3k
Justin M. Rothfuss United States	15	720 1.9×	27 0.2×	9 0.1×	19 0.1×	112 1.1×	18	973
Chie Hatori Japan	14	279 0.7×	59 0.4×	321 2.1×	3 0.0×	96 1.0×	19	747

Countries citing papers authored by Brent Douty

Since Specialization

Citations

This map shows the geographic impact of Brent Douty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent Douty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent Douty more than expected).

Fields of papers citing papers by Brent Douty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent Douty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent Douty. The network helps show where Brent Douty may publish in the future.

Co-authorship network of co-authors of Brent Douty

This figure shows the co-authorship network connecting the top 25 collaborators of Brent Douty. A scholar is included among the top collaborators of Brent Douty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent Douty. Brent Douty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Koblish, Holly K., Liang-Chuan Wang, Michael Hansbury, et al.. (2015). Abstract C103: The combination of PI3kδ-selective inhibition and immunomodulation shows efficacy in solid tumor models. Molecular Cancer Therapeutics. 14(12_Supplement_2). C103–C103. 5 indexed citations

Wang, Liang‐Chuan S., Holly K. Koblish, Michael Hansbury, et al.. (2015). Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents. Journal for ImmunoTherapy of Cancer. 3(S2). 2 indexed citations

Yue, Eddy W., Brent Douty, Brian Wayland, et al.. (2009). Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model. Journal of Medicinal Chemistry. 52(23). 7364–7367. 187 indexed citations

Douty, Brent, Brian Wayland, J. Paul, et al.. (2007). Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Bioorganic & Medicinal Chemistry Letters. 18(1). 66–71. 55 indexed citations

Paul, J., Lucie Gonneville, Milton C. Hillman, et al.. (2006). Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B. Journal of Biological Chemistry. 281(49). 38013–38021. 55 indexed citations

Paul, J., Lucie Gonneville, Milton C. Hillman, et al.. (2006). Structural Basis for Inhibition of Protein-tyrosine Phosphatase 1B by Isothiazolidinone Heterocyclic Phosphonate Mimetics. Journal of Biological Chemistry. 281(43). 32784–32795. 61 indexed citations

Yue, Eddy W., Brian Wayland, Brent Douty, et al.. (2006). Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: Synthesis and structure–activity relationships of a peptide scaffold. Bioorganic & Medicinal Chemistry. 14(17). 5833–5849. 44 indexed citations

Glunz, Peter W., Brent Douty, & Carl P. Decicco. (2003). Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(5). 785–788. 18 indexed citations

Glunz, Peter W., Brent Douty, & Carl P. Decicco. (2003). Design and Synthesis of Bicyclic Pyrimidinone‐Based HCV NS3 Protease Inhibitors.. ChemInform. 34(30). 1 indexed citations

10.

Salvino, Joseph M., Peter R. Seoane, Brent Douty, et al.. (1995). Structure activity relationships of non-peptide bradykinin B2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 5(4). 357–362. 8 indexed citations

11.

Douty, Brent, Joseph M. Salvino, Peter R. Seoane, & Roland E. Dolle. (1995). Synthesis of non-peptide bradykinin B2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 5(4). 363–366. 5 indexed citations

12.

Sawutz, David G., Joseph M. Salvino, Peter R. Seoane, et al.. (1994). Synthesis, Characterization, and Conformational Analysis of the D/L-Tic7 Stereoisomers of Bradykinin Receptor Antagonist D-Arg0[Hyp3,Thi5,D-Tic7,Oic8]bradykinin. Biochemistry. 33(9). 2373–2379. 19 indexed citations

13.

Sawutz, David G., Joseph M. Salvino, Roland E. Dolle, et al.. (1994). The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.. Proceedings of the National Academy of Sciences. 91(11). 4693–4697. 73 indexed citations

14.

Salvino, Joseph M., et al.. (1993). Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor. Journal of Medicinal Chemistry. 36(17). 2583–2584. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact